If you only include drop-out numbers directly related to the drug (so exclude unrelated deaths, non-compliance with drug administration etc), it was actually under 10% drop out rate. I recall this may have been elaborated on by the learned contributors here at the time results were released. Great to see that there still using the extended study in recent presentations too.
- Forums
- ASX - By Stock
- Ann: Positive topline results from Phase 3 trial in Rett syndrome
If you only include drop-out numbers directly related to the...
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.02 |
Change
-1.250(6.17%) |
Mkt cap ! $2.428B |
Open | High | Low | Value | Volume |
$20.40 | $20.50 | $18.82 | $19.92M | 1.034M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1652 | $19.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.03 | 11612 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1652 | 19.000 |
2 | 1188 | 18.980 |
1 | 1000 | 18.960 |
3 | 7922 | 18.950 |
1 | 2560 | 18.930 |
Price($) | Vol. | No. |
---|---|---|
19.040 | 1819 | 1 |
19.140 | 3094 | 3 |
19.170 | 1188 | 2 |
19.240 | 3000 | 1 |
19.250 | 2902 | 1 |
Last trade - 16.10pm 04/06/2024 (20 minute delay) ? |
|
|||||
Last
$19.10 |
  |
Change
-1.250 ( 6.19 %) |
|||
Open | High | Low | Volume | ||
$20.39 | $20.46 | $18.83 | 299764 | ||
Last updated 15.59pm 04/06/2024 ? |
Featured News
NEU (ASX) Chart |